Authors report the characterization of secukinumab n-glycans using mass spectrometry and fluorescence analysis, suggesting significant implications for immunobiological research.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Caminha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: